Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Debt Issuance
confidence 85%
filed 2026-07-20
Item 1.01
Universal Electronics' subsidiary GTY entered into a Line of Credit Agreement and Working Capital Loan Contract with Bank of China Limited on July 15, 2026, establishing a borrowing capacity of 130,000,000 RMB. This constitutes creation of new direct financial obligations under Item 1.01, fitting the debt_issuance category. The material amount and multi-year term (through July 2027) make this material to investors assessing the registrant's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
Zions Bancorporation announced its second quarter 2026 financial results on July 20, 2026, disclosing net earnings of $452 million and diluted EPS of $3.05. The press release (Exhibit 99.1) provides comprehensive quarterly financial results including net interest income, noninterest income and expense, loan portfolio metrics, credit quality, and capital ratios. This is a standard quarterly earnings release filed under Item 2.02, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-20
Item 2.02
Danaher issued a press release on July 21, 2026 announcing financial results for the quarter ended June 26, 2026, disclosing net earnings of $870 million ($1.23 per diluted share, up 60% YoY), revenues of $6.3 billion (up 5.5% YoY), and raising full-year 2026 adjusted EPS guidance to $8.45–$8.60. This is a standard quarterly earnings release filed under Item 2.02 with consolidated financial statements and forward-looking guidance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-20
Item 5.02
The filing discloses adoption of the 2026 Short-Term Incentive Plan establishing annual cash incentive compensation for named executive officers with specific performance goals and payout schedules, and an amended employment agreement reducing CEO Todd Brickhouse's base salary to $1,750,000 effective July 25, 2026. These are compensatory arrangements for officers that would materially affect investor assessment of executive compensation structure and CEO pay.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
Washington Trust Bancorp disclosed second quarter 2026 unaudited financial results via press release dated July 20, 2026, reporting net income of $16.0 million ($0.83 per diluted share), up from prior quarter and year-ago periods. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases on Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
Dynex Capital issued a press release on July 20, 2026 announcing its second quarter 2026 financial results, including comprehensive income of $0.80 per common share, net income of $0.80 per common share, book value per share of $12.90, and a total economic return of 6.4%. The filing explicitly states under Item 2.02 that the Company "issued a press release announcing its financial results as of and for the quarter ended June 30, 2026," with the full press release attached as Exhibit 99.1. This is a standard quarterly earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-20
Item 2.02
BOK Financial Corporation issued a press release on July 20, 2026, announcing financial results for the three and six months ended June 30, 2026, reporting quarterly earnings of $177 million ($2.92 per diluted share), net interest income of $351.8 million, and fees and commissions revenue of $202.0 million.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-20
The filing discloses the Board of Directors' declaration of a regular quarterly cash dividend of $0.125 per share of Class A common stock, payable on September 4, 2026. This is a straightforward dividend distribution announcement, disclosed via Item 7.01 (Regulation FD Disclosure) with a supporting press release. Dividend declarations are material events affecting shareholder value and capital allocation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-20
Item 3.02
EWSB Bancorp closed a private placement of 88,318 shares of Series A Junior Non-Voting Participating Preferred Stock for $883,180 on July 16, 2026, concluding a rights offering to accredited investors. This is a classic dilutive issuance under Item 3.02 — an unregistered sale of equity securities that increases the company's capitalization and dilutes existing shareholders, particularly material for a small-cap bank raising capital through a preferred equity offering.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 35%
filed 2026-07-20
Item 8.01
The filing discloses the Company's exercise of its redemption option for $6.5 million aggregate principal of its 8.50% Notes due 2029, to be redeemed at par plus accrued interest on August 19, 2026. While this is a redemption (retirement) of existing debt rather than issuance of new debt, it represents a material capital event affecting the Company's debt structure and cash position. The most closely fitting category is debt_issuance, though the event is technically a debt retirement; no specific "debt_retirement" or "debt_redemption" category exists in the taxonomy, making this classification uncertain.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-20
Item 8.01
The filing discloses a declaration and approval by the Board of Directors of a regular quarterly dividend of $0.07 per common share, payable August 17, 2026, to shareholders of record as of August 7, 2026. This is a straightforward dividend distribution announcement, which is material to shareholders as it represents a return of capital and signals management's confidence in cash flow.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
Wintrust Financial Corporation announced record net income of $461.1 million for the first six months of 2026 and record quarterly net income of $233.7 million for Q2 2026 on July 20, 2026. The disclosure includes a press release (Exhibit 99.1) with detailed financial results, balance sheet metrics, net interest income, asset quality, and business segment performance. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 93%
filed 2026-07-20
Item 2.03
EPR Properties entered into a Fifth Amended, Restated and Consolidated Credit Agreement on July 17, 2026, creating $1.6 billion in new direct financial obligations: a $1.0 billion senior unsecured revolving credit facility and a $600.0 million senior unsecured delayed draw term loan facility, with an accordion feature to increase total capacity to $2.6 billion. The new facilities address upcoming debt maturities in August and December 2026 and provide enhanced borrowing flexibility.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-20
The 6-K discloses the results of Formula Systems' 2026 annual general meeting of shareholders held on July 20, 2026. The filing reports voting outcomes on eight proposals, including re-election of five board members (Marek Panek, Rafal Kozlowski, Itay Meroz, Karolina Rzonca-Bajorek, and Gabriela Żukowicz) and re-appointment of the independent auditor (Ziv Haft/BDO Israel), all of which were approved. This is a classic shareholder_vote_results disclosure under the 8-K taxonomy Item 5.07 equivalent.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-20
EX-99.1
The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states "The Board has appointed Joshua Girnun...and Donal Carroll...as new directors" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-20
EX-99.1
Seabridge Gold has executed an unsecured, short-term loan agreement for up to US$100 million with a strategic investor. This is a creation of a new direct financial obligation — a debt facility with specified terms (7% interest, maturity December 31, 2026, drawable in minimum US$10 million tranches). The company intends to draw on the facility to strengthen liquidity, making this a material debt issuance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-20
Item 5.07
ZeroStack Corp. held an annual shareholder meeting at which eight proposals were submitted to a vote, including director elections, auditor reappointment, equity issuance approval, equity plan amendments, executive compensation approval, incorporation jurisdiction change, bylaw amendment establishing a classified board with staggered director terms, and meeting adjournment authority. All eight proposals were approved by shareholders.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-07-20
Item 8.01
NeoGenomics settled a Department of Justice/Office of Inspector General investigation concerning consulting services provided under its Laboratory Collaboration Initiative program, agreeing to pay $9,813,260 plus interest. The settlement resolves a matter the company self-disclosed in November 2021 and for which it had previously accrued $11.2 million in reserves, materially affecting the company's regulatory compliance and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
Lightwave Logic appointed Fred A. Graffam III as Chief Financial Officer, effective immediately on July 20, 2026. Graffam brings over 20 years of financial leadership experience and prior CFO roles at Fidium, Ascent Capital Group, and DigitalGlobe. His compensation package includes a base salary of $450,000, a performance bonus up to 40%, a sign-on cash bonus of $70,000, and restricted stock units valued at $2,400,000.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-20
Item 1.01
The Company entered into a material definitive agreement to purchase a building and land in Columbus, Georgia for $15 million in cash plus a contingent earnout note with up to $15 million in additional payments tied to power delivery milestones. This constitutes a material acquisition of a property asset for use as a data center, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement), and would materially affect a reasonable investor's assessment of the registrant's capital deployment and strategic direction.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-20
Item 1.01
The Company entered into a new $2.250 billion unsecured revolving credit facility on July 14, 2026, replacing a prior $1.825 billion facility with a 5-year maturity (July 2031), interest rate tied to Term SOFR plus margin, and participation by 18 relationship banks led by JPMorgan Chase.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-20
Item 8.01
The Company entered into a new $400 million, 3-year senior unsecured term loan facility on July 14, 2026, replacing two prior facilities ($250 million unsecured and $250 million delayed draw), with interest rate structure of Term SOFR plus 1.45% margin and standard debt covenants.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 7.01
Element Solutions disclosed a proposed acquisition by Solstice Advanced Materials Inc. via an investor update presentation filed on July 20, 2026. The Item 7.01 disclosure explicitly states "Solstice issued an investor update presentation regarding the proposed acquisition of Element Solutions Inc" and references anticipated transaction benefits, synergies, and combined company financial metrics. This constitutes material M&A activity requiring disclosure under Item 1.01 or related provisions, even though furnished under Item 7.01 (Regulation FD).
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-20
EX-99.1
Baosheng announced a non-binding MOU with Zhongcheng Kexin to jointly develop an AI marketing and service platform for scenic areas. While the MOU is explicitly non-binding and creates no binding obligations, it represents a material strategic collaboration that extends Baosheng's AI capabilities into a new vertical (cultural tourism). The disclosure emphasizes this as "a pivotal step" and "important growth pillar," with management commentary indicating significant strategic importance to the company's AI commercialization roadmap and revenue targets. This is an operational/strategic partnership announcement rather than a binding M&A transaction, making `operational_other` the most appropriate classification.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-20
EX-99.1
The exhibit discloses Above Food's engagement of counsel to appeal a Nasdaq delisting determination before the Nasdaq Listing and Hearing Review Council. The company explicitly states it "has requested review of Nasdaq's prior delisting determination" and references an outstanding Form 20-F filing obligation under Listing Rule 5250(c)(1). This is a material delisting-risk disclosure under Item 3.01 equivalent, as the company faces potential loss of listing due to non-compliance with filing requirements.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-07-20
Item 1.01
World Omni Select Auto Trust 2026-A issued approximately $695.2 million in aggregate principal amount of asset-backed notes across six classes (A-1, A-2a, A-2b, A-3, B, and C), secured by motor vehicle retail installment sale contracts. The transaction was structured under an Underwriting Agreement dated July 16, 2026, with multiple classes carrying varying principal amounts and interest rates.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
The filing discloses the appointment of Kevin O'Connor as President of Hanover Bancorp, Inc. and Hanover Community Bank, effective July 27, 2026. While the disclosure includes compensatory details (base salary, incentive compensation eligibility, and a 10,000-share restricted stock award vesting over five years), the principal action and focus of Item 5.02(c) is the appointment itself. The compensation terms are incidental to the appointment announcement and do not constitute a standalone compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-20
Item 2.02
Mesa Royalty Trust issued a press release on July 20, 2026 announcing its royalty income and income distribution for July 2026, specifically that there will be no distribution paid for the month because "costs, charges and expenses attributable to the Trust's royalty properties exceeded the revenue received." This is a periodic financial results disclosure typical of earnings releases under Item 2.02, and the zero-distribution outcome is material to unitholders' assessment of the Trust's cash generation and distribution capacity.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-20
Item 5.02
The company granted RSUs and PSUs to CEO Asim Akram and CFO Robert Nadolny, and amended their RSU Award Agreements and employment agreements to modify change-of-control vesting provisions and establish new equity award treatment in M&A scenarios.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-20
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.35 per share, representing a $0.10 increase from the prior quarterly dividend of $0.25 per share, payable on August 11, 2026. This is a clear dividend distribution event. The increase in dividend is material to investors as it signals improved capital position and management confidence in future earnings, affecting shareholder returns.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 1.01
Elutia entered into a definitive Asset Purchase Agreement on July 16, 2026, to sell substantially all assets of its SimpliDerm Business (Women's Health segment) to Cellution Biologics for up to $11 million in cash and milestone payments, completing its strategic process and providing non-dilutive capital to support NXT-41x pipeline development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 8.01
This Item 8.01 filing discloses a material acquisition of WildFire Intermediate Holdings, LLC by Magnolia Oil & Gas Operating LLC (a subsidiary of Magnolia Oil & Gas Corp). The filing incorporates audited and unaudited financial statements of the seller, pro forma combined financial information, and reserve estimates—all standard documentation for a material M&A transaction. The target comprises approximately 810,000 net acres in Texas with proved reserves of 271.2 MMBoe and expected production of 53 MBoe/d, representing a substantial acquisition of oil and gas assets.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-20
Item 2.02
Eagle Nuclear Energy Corp. issued a press release on July 20, 2026, announcing its "financial and operating results for the quarter ended May 31, 2026," which is furnished as Exhibit 99.1. The press release provides a corporate update covering operational milestones, liquidity position ($28.1 million cash, no debt), and strategic progress on the Aurora uranium project and SMR technology platform. This is a standard quarterly earnings/results disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-20
Item 2.03
The company completed a sale-leaseback transaction of 26 company-owned store locations, generating approximately $77 million in net proceeds that will be deployed toward debt reduction. This transaction creates a new direct financial obligation in the form of lease liabilities on the balance sheet.
View raw filing on EDGAR →
8-K
Material Impairment
confidence 95%
filed 2026-07-20
Item 2.06
The company divested Maple Street Biscuit Company (MSBC) assets to Biscuit Belly, LLC and closed 16 remaining MSBC locations, resulting in expected non-cash impairment charges of approximately $37 million to $39 million and additional cash charges of $6 million to $8 million in Q4 fiscal 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-20
Item 5.07
This Item 5.07 disclosure reports the results of Transcode Therapeutics' 2026 Annual Meeting of Stockholders held on July 20, 2026. The filing details voting outcomes on seven proposals, including approval of convertible preferred stock issuances (Proposals 1–2), a Standby Equity Purchase Agreement and convertible notes (Proposal 3), election of six directors (Proposal 4), amendment to the 2021 Stock Option and Incentive Plan (Proposal 5), ratification of the independent auditor (Proposal 6), and adjournment authority (Proposal 7). All proposals were approved. The disclosure is material because shareholder approval of dilutive equity issuances and director elections directly affects investor interests and capital structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-20
Item 2.02
VOC Energy Trust announced a quarterly distribution of $4,760,000 or $0.28 per unit to unitholders of record on July 30, 2026, payable August 14, 2026. This is a routine but material distribution of cash proceeds from the Trust's net profits interest in oil and gas properties, disclosed via press release under Item 2.02. The distribution amount and per-unit payment are clearly stated, making this a dividend_distribution event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-20
Item 2.02
First United Corporation issued a press release on July 20, 2026 disclosing financial results for the three- and six-month periods ended June 30, 2026, including consolidated net income of $5.7 million ($0.87 per diluted share) for Q2 2026 and $12.3 million ($1.90 per diluted share) for the six-month period, with a net interest margin of 3.98%.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
The Board of Directors appointed Tara Bunch as a director on July 16, 2026. Ms. Bunch brings significant operational and governance experience from senior roles at Airbnb, Apple, and Hewlett-Packard, as well as board service at The Vanguard Group.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-20
Item 1.01
AdaptHealth entered into a definitive asset purchase agreement on July 19, 2026, to divest its Diabetes Health business to Cardinal Health (a subsidiary of RGH Enterprises, LLC) for $235 million in cash. This is a material disposition of a business segment, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement). The transaction is described as "the latest – and most significant – step" in the company's portfolio restructuring and will materially affect the company's revenue, EBITDA margins, and capital structure going forward, with the Diabetes Health segment to be treated as discontinued operations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-20
Item 2.02
SmartFinancial issued a press release on July 20, 2026, reporting Q2 2026 quarterly earnings results with net income of $16.3 million ($0.96 per diluted share), including detailed financial metrics, balance sheet trends, and management commentary. The disclosure was furnished under Item 2.02 with supporting investor presentation materials referenced for the July 21, 2026 earnings conference call.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-20
Item 5.02
William R. Nelson resigned from his position as President of the Republic Processing Group (RPG) effective August 28, 2026, to accept an executive opportunity elsewhere. While the filing also mentions Brent Shuman assuming the interim role, the principal disclosed action is Nelson's departure. The resignation of a division president is material to investors assessing management stability and operational continuity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-20
Item 1.01
SmartKem entered into a Securities Purchase Agreement on March 30, 2026, and amended it on July 16, 2026, to sell Series A convertible preferred stock and warrants to institutional investors. The offering raised approximately $17.1 million and includes warrants to purchase approximately 36.7 million shares of common stock, materially diluting existing shareholders upon conversion and exercise.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-20
EX-99.1
This news release announces a material operational milestone at Eldorado Gold's Skouries copper-gold project in Greece: first ore has been crushed through the commissioned crushing circuit, commissioning activities are advancing, and the company targets first concentrate production in Q3 2026 and commercial production in Q4 2026. While this is a significant project development, it does not fit the specific event categories (not an earnings release, M&A activity, impairment, or other named types). The disclosure is clearly operational and strategic—a major construction and development milestone for a material project—making it an operational_other event that would affect a reasonable investor's assessment of the company's progress toward production.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-20
EX-99.1
Osisko Development Corp. changed its corporate name to Osisko Gold Group Inc. and relocated its registered office from Québec to Ontario, effective July 14, 2026, following shareholder approval on June 23, 2026. The name change triggered corresponding ticker symbol changes across TSXV, NYSE, and Nasdaq (ODV to OGG, ODVWZ to OGGWZ), along with new CUSIP and ISIN numbers.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-20
Item 8.01
Oncolytics announced that the FDA granted Fast Track Designation for pelareorep in combination with a checkpoint inhibitor for treating advanced squamous cell carcinoma of the anal canal. This is a significant regulatory milestone that accelerates development and review timelines, represents the third Fast Track designation in gastrointestinal cancers, and addresses an estimated $1 billion market with no approved therapies for second-line patients. While this is a positive regulatory development rather than a traditional operational event, it is a material strategic and regulatory milestone that would affect investor assessment of the company's development trajectory and de-risking of its pipeline.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
This is a clear earnings release disclosing quarterly and six-month financial results for Farmers & Merchants Bancorp. The press release reports record second quarter net income of $24.7 million, diluted EPS of $36.39 (up 10.47% YoY), and detailed financial metrics including net interest income, balance sheet growth, and capital ratios. The filing explicitly states "On July 20, 2026, Farmers & Merchants Bancorp issued a press release concerning financial results for the three-months and six-months ended June 30, 2026" and includes comprehensive financial highlights and management commentary typical of an earnings announcement.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-20
EX-99.1
This press release announces clinical progress in a Phase 2 trial of MP0317 for cholangiocarcinoma, including dosing of first patients, nine activated trial sites, and expected data in 2027. While this is a material operational milestone for a clinical-stage biotech company, it does not fit the specific `earnings_release` category (no financial results disclosed) nor any other named event type. The disclosure is clearly operational—a significant clinical development milestone—making `operational_other` the appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
ServisFirst Bancshares issued a press release on July 20, 2026 announcing second quarter 2026 operating results, disclosing net income of $85.8 million (up 39.7% year-over-year), diluted EPS of $1.57 (up 40% year-over-year), and key metrics including loan growth, deposit growth, and net interest margin expansion.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-20
EX-99.1
Enzo Villani, who was Executive Chairman and Chief Investment Officer, has been appointed to serve as President of Alpha Compute Corp, effective July 16, 2026. This is a material executive appointment expanding his role to include "broader responsibility for corporate strategy, capital allocation, and operational execution." The appointment of a senior executive to a new C-suite position is material to investors assessing company leadership and governance.
View raw filing on EDGAR →